{"id":"https://openalex.org/W2092192575","doi":"https://doi.org/10.1111/j.1524-4733.2008.00495.x","title":"Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study","display_name":"Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study","publication_year":2009,"publication_date":"2009-01-12","ids":{"openalex":"https://openalex.org/W2092192575","doi":"https://doi.org/10.1111/j.1524-4733.2008.00495.x","mag":"2092192575","pmid":"https://pubmed.ncbi.nlm.nih.gov/19900255"},"language":"en","primary_location":{"id":"doi:10.1111/j.1524-4733.2008.00495.x","doi":"https://doi.org/10.1111/j.1524-4733.2008.00495.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1524-4733.2008.00495.x","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1111/j.1524-4733.2008.00495.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002758767","display_name":"Jordi Alonso","orcid":"https://orcid.org/0000-0001-8627-9636","observed_orcids":["https://orcid.org/0000-0001-8627-9636"]},"institutions":[{"id":"https://openalex.org/I4210136145","display_name":"Municipal Institute for Medical Research","ror":"https://ror.org/039evc422","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210136145"]},{"id":"https://openalex.org/I4210156109","display_name":"Hospital del Mar Research Institute","ror":"https://ror.org/042nkmz09","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210156109","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Jordi Alonso","raw_affiliation_strings":["Health Services Research Unit, Institut Municipal d'Investigaci\u00f3 M\u00e8dica (IMIM-Hospital del Mar), Barcelona, Spain. jalonso@imim.es","Health Services Research Unit, Institut Municipal d'Investigaci\u00f3 M\u00e8dica (IMIM-Hospital del Mar), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Services Research Unit, Institut Municipal d'Investigaci\u00f3 M\u00e8dica (IMIM-Hospital del Mar), Barcelona, Spain. jalonso@imim.es","institution_ids":["https://openalex.org/I4210136145","https://openalex.org/I4210156109"]},{"raw_affiliation_string":"Health Services Research Unit, Institut Municipal d'Investigaci\u00f3 M\u00e8dica (IMIM-Hospital del Mar), Barcelona, Spain","institution_ids":["https://openalex.org/I4210136145","https://openalex.org/I4210156109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056510016","display_name":"Tim J. Croudace","orcid":"https://orcid.org/0000-0001-8346-7463","observed_orcids":["https://orcid.org/0000-0001-8346-7463"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tim Croudace","raw_affiliation_strings":["Department of Psychiatry, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210156194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003889471","display_name":"Jacqueline Brown","orcid":"https://orcid.org/0000-0002-1130-6414","observed_orcids":["https://orcid.org/0000-0002-1130-6414"]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jacqueline Brown","raw_affiliation_strings":["Eli Lilly and Company, Windlesham, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Windlesham, Surrey, UK","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069075755","display_name":"I. Gasquet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210164847","display_name":"H\u00f4pital Paul-Brousse","ror":"https://ror.org/05n7yzd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210164847","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Gasquet","raw_affiliation_strings":["Public Health Department-Paul Brousse Hospital (AP-HP), Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Public Health Department-Paul Brousse Hospital (AP-HP), Villejuif, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210164847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007323180","display_name":"Martin Richard John Knapp","orcid":"https://orcid.org/0000-0003-1427-0215","observed_orcids":["https://orcid.org/0000-0003-1427-0215"]},"institutions":[{"id":"https://openalex.org/I909854389","display_name":"London School of Economics and Political Science","ror":"https://ror.org/0090zs177","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I909854389"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin R.J. Knapp","raw_affiliation_strings":["Centre for the Economics of Mental Health, Institute of Psychiatry, London, UK","PSSRU, Social Policy Department, London School of Economics and Political Science, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for the Economics of Mental Health, Institute of Psychiatry, London, UK","institution_ids":[]},{"raw_affiliation_string":"PSSRU, Social Policy Department, London School of Economics and Political Science, London, UK","institution_ids":["https://openalex.org/I909854389"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101744608","display_name":"David L. Suarez","orcid":"https://orcid.org/0000-0003-4582-6116","observed_orcids":["https://orcid.org/0000-0003-4582-6116"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Su\u00e1rez","raw_affiliation_strings":["Sant Joan de D\u00e9u-SSM, Fundaci\u00f3 Sant Joan de D\u00e9u, Sant Boi, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sant Joan de D\u00e9u-SSM, Fundaci\u00f3 Sant Joan de D\u00e9u, Sant Boi, Barcelona, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107876782","display_name":"Diego Novick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Diego Novick","raw_affiliation_strings":["Eli Lilly and Company, Windlesham, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Windlesham, Surrey, UK","institution_ids":["https://openalex.org/I4210095227"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5002758767"],"corresponding_institution_ids":["https://openalex.org/I4210136145","https://openalex.org/I4210156109"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":2.3032,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.87658103,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"12","issue":"4","first_page":"536","last_page":"543"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13944","display_name":"Psychiatric care and mental health services","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9760000109672546},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9319999814033508},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8899999856948853},{"id":"https://openalex.org/keywords/eq-5d","display_name":"EQ-5D","score":0.7820000052452087},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.8600000143051147},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":1.0},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.7279999852180481},{"id":"https://openalex.org/keywords/social-activity","display_name":"social activity","score":0.7310000061988831},{"id":"https://openalex.org/keywords/employment","display_name":"employment","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7259613871574402},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.666462242603302},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.6632615923881531},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6465179324150085},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6348249912261963},{"id":"https://openalex.org/C2778464720","wikidata":"https://www.wikidata.org/wiki/Q19843151","display_name":"EQ-5D","level":4,"score":0.6215884685516357},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.6157503128051758},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.47955986857414246},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47425830364227295},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.47284629940986633},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.46919605135917664},{"id":"https://openalex.org/C3019006561","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Health related quality of life","level":3,"score":0.41789448261260986},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16860681772232056},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.1107487678527832},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006305","descriptor_name":"Health Status Indicators","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010045","descriptor_name":"Outpatients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016001","descriptor_name":"Confidence Intervals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1524-4733.2008.00495.x","doi":"https://doi.org/10.1111/j.1524-4733.2008.00495.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1524-4733.2008.00495.x","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},{"id":"pmid:19900255","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19900255","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research","raw_type":"Journal Article"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire_cris_publications/347b3162-d405-44cd-83ab-b11cd42c9a9b","doi":null,"is_oa":false,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/347b3162-d405-44cd-83ab-b11cd42c9a9b","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alonso, J, Croudace, T, Brown, J, Gasquet, I, Knapp, M R J, Su\u00e1rez, D & Novick, D 2009, 'Health-related quality of life (HRQL) and continuous antipsychotic treatment : 3-year results from the Schizophrenia Health Outcomes (SOHO) study', Value in Health, vol. 12, no. 4, pp. 536-543. https://doi.org/10.1111/j.1524-4733.2008.00495.x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/dfa795bf-dc2c-40d4-b346-3ea1618e0365","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/dfa795bf-dc2c-40d4-b346-3ea1618e0365","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Alonso, J, Croudace, T, Brown, J, Gasquet, I, Knapp, M R J, Suarez, D & Novick, D 2009, 'Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study', Value in Health, vol. 12, no. 4, pp. 536 - 543. https://doi.org/10.1111/j.1524-4733.2008.00495.x","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/j.1524-4733.2008.00495.x","doi":"https://doi.org/10.1111/j.1524-4733.2008.00495.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1524-4733.2008.00495.x","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W162066932","https://openalex.org/W1560304345","https://openalex.org/W1587086507","https://openalex.org/W1967728981","https://openalex.org/W1971003926","https://openalex.org/W1976874578","https://openalex.org/W1981405738","https://openalex.org/W2000446731","https://openalex.org/W2009966734","https://openalex.org/W2010371891","https://openalex.org/W2011554834","https://openalex.org/W2041474698","https://openalex.org/W2050936425","https://openalex.org/W2071001416","https://openalex.org/W2082246284","https://openalex.org/W2084312105","https://openalex.org/W2085659479","https://openalex.org/W2096635847","https://openalex.org/W2108022657","https://openalex.org/W2109196233","https://openalex.org/W2121690051","https://openalex.org/W2127772714","https://openalex.org/W2132144498","https://openalex.org/W2133102517","https://openalex.org/W2139773071","https://openalex.org/W2150291618","https://openalex.org/W2153367330","https://openalex.org/W2159155203","https://openalex.org/W2161926599","https://openalex.org/W2164615737","https://openalex.org/W2168513289","https://openalex.org/W2168875379","https://openalex.org/W2168991419","https://openalex.org/W2314449892","https://openalex.org/W2502806512","https://openalex.org/W3125683136","https://openalex.org/W4297686017"],"related_works":["https://openalex.org/W2039818490","https://openalex.org/W2139773071","https://openalex.org/W7095850496","https://openalex.org/W1999647669","https://openalex.org/W2082758960","https://openalex.org/W7155055646","https://openalex.org/W2050528001","https://openalex.org/W4297088869","https://openalex.org/W1969811778","https://openalex.org/W2019652822"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}